Libra Therapeutics
PrivateLast Round
Grant
Dec 20, 2024
Total Funding Raised
$34M
Company Overview
Libra Therapeutics is a biotechnology company that develops novel disease-modifying therapeutics to restore cellular homeostasis and slow the progression of neurodegenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Libra Therapeutics Comparables
Compare Libra Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Casma Therapeutics | 90% | |
| Nine Square Therapeutics | 89% | |
| Lysoway Therapeutics | 87% |
Libra Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 20, 2024 | ||||
| Series A | Sep 23, 2020 |
Key People
Founding team and executive leadership
Libra Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Sixty Degree Capital | Series A |
| Boehringer Ingelheim | Series A |
| Dolby Family Ventures | Series A |
| Epidarex Capital | Series A |
| Santé Ventures | Series A |
| Boehringer Ingelheim Venture Fund | Series A |
Libra Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Libra Therapeutics's valuation, stock price, and market status.
Is Libra Therapeutics a public or private company?
Libra Therapeutics is a private company.
What is the current stock price of Libra Therapeutics?
Libra Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Libra Therapeutics worth (valuation)?
Valuation information for Libra Therapeutics is not publicly available.
Can I buy Libra Therapeutics stock?
Libra Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Libra Therapeutics's last funding round?
Libra Therapeutics's most recent funding round was Grant on December 20, 2024.
Who are the main investors in Libra Therapeutics?
Key investors in Libra Therapeutics include Boehringer Ingelheim, Epidarex Capital, Boehringer Ingelheim Venture Fund.
Will Libra Therapeutics IPO soon?
No public IPO plans have been announced for Libra Therapeutics.
How can I track Libra Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Libra Therapeutics's secondary market activity and sign up for updates.